---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-182549"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:11:22.286912+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics raises $10M via registered direct offering with warrants

## Summary
- Gross proceeds ~$10M from sale of 2.8M shares, 446,753 pre-funded warrants, and warrants for 6.5M shares.
- Combined offering price $3.08 per share/warrant unit; warrants exercisable at $3.08 starting six months after closing.
- Series A warrants expire 18 months from issuance; Series B warrants expire 5.5 years from issuance.
- Directors and officers subject to 60-day lock-up; company restricted from issuing new securities for up to 60 days.
- Closing expected July 23, 2024; Maxim Group acted as placement agent with 6% fee.

## SEC filing metadata
- accession: 0001193125-24-182549
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000119312524182549/0001193125-24-182549-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000119312524182549/d873880d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-182549
- JSON: https://secwatch.observer/filing/0001193125-24-182549.json
- Plain text: https://secwatch.observer/filing/0001193125-24-182549.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.